Synthesis and biological evaluation of benzimidazole-oxindole conjugates as microtubule-targeting agents. 2015

Ahmed Kamal, and B Nagaseshadri, and V Lakshma Nayak, and Vunnam Srinivasulu, and Manda Sathish, and Jeevak Sopanrao Kapure, and C Suresh Reddy
Medicinal Chemistry and Pharmacology, CSIR - Indian Institute of Chemical Technology, Hyderabad 500007, India; Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad 500 037, India. Electronic address: ahmedkamal@iict.res.in.

A series of benzimidazole-oxindole conjugates were synthesized and evaluated for their cytotoxic activity. The cytotoxicity assay results suggest that conjugates 5c and 5p exhibit promising cytotoxicity against human breast cancer cell line (MCF-7). The Cell cycle analysis revealed that these conjugates induced cell cycle arrest at G2/M phase in MCF-7 cells. The tubulin polymerization assay results suggested that these conjugates inhibit tubulin polymerization with IC50 values 1.12 and 1.59μM respectively. Immunofluorescence analysis also suggested that these conjugates effectively inhibited the microtubule assembly in MCF-7 cells. Further, molecular docking studies indicated that these conjugates 5c and 5p interact and binds efficiently with the tubulin protein. By and large, the results demonstrated that these benzimidazole-oxindole conjugates possess cytotoxic property by inhibiting the tubulin polymerization.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008870 Microtubules Slender, cylindrical filaments found in the cytoskeleton of plant and animal cells. They are composed of the protein TUBULIN and are influenced by TUBULIN MODULATORS. Microtubule
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078183 Oxindoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl and a carbonyl at the pyrrole ring typically at the 2-position. Ajmalicine Oxindole,Ajmalicine Oxindoles,Ajmalicine-Type Oxindole,Ajmalicine-Type Oxindoles,Indolinone,Indolinone Derivative,Macroline Oxindole,Macroline Oxindoles,Macroline-Type Oxindole,Macroline-Type Oxindoles,Oxazolidinone Derivative,Oxindole Alkaloid,Oxindole Alkaloid Derivative,Oxindole Derivative,Indolinone Derivatives,Indolinones,Oxazolidinone Derivatives,Oxindole Alkaloid Derivatives,Oxindole Alkaloids,Oxindole Derivatives,Ajmalicine Type Oxindole,Ajmalicine Type Oxindoles,Alkaloid Derivative, Oxindole,Alkaloid, Oxindole,Derivative, Indolinone,Derivative, Oxazolidinone,Derivative, Oxindole,Derivative, Oxindole Alkaloid,Macroline Type Oxindole,Macroline Type Oxindoles,Oxindole, Ajmalicine,Oxindole, Ajmalicine-Type,Oxindole, Macroline,Oxindole, Macroline-Type,Oxindoles, Ajmalicine,Oxindoles, Ajmalicine-Type,Oxindoles, Macroline,Oxindoles, Macroline-Type
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Ahmed Kamal, and B Nagaseshadri, and V Lakshma Nayak, and Vunnam Srinivasulu, and Manda Sathish, and Jeevak Sopanrao Kapure, and C Suresh Reddy
December 2013, ChemMedChem,
Ahmed Kamal, and B Nagaseshadri, and V Lakshma Nayak, and Vunnam Srinivasulu, and Manda Sathish, and Jeevak Sopanrao Kapure, and C Suresh Reddy
April 2018, Bioorganic chemistry,
Ahmed Kamal, and B Nagaseshadri, and V Lakshma Nayak, and Vunnam Srinivasulu, and Manda Sathish, and Jeevak Sopanrao Kapure, and C Suresh Reddy
March 2015, European journal of medicinal chemistry,
Ahmed Kamal, and B Nagaseshadri, and V Lakshma Nayak, and Vunnam Srinivasulu, and Manda Sathish, and Jeevak Sopanrao Kapure, and C Suresh Reddy
November 2015, Bioorganic & medicinal chemistry letters,
Ahmed Kamal, and B Nagaseshadri, and V Lakshma Nayak, and Vunnam Srinivasulu, and Manda Sathish, and Jeevak Sopanrao Kapure, and C Suresh Reddy
March 2015, Bioorganic & medicinal chemistry,
Ahmed Kamal, and B Nagaseshadri, and V Lakshma Nayak, and Vunnam Srinivasulu, and Manda Sathish, and Jeevak Sopanrao Kapure, and C Suresh Reddy
August 2023, Future medicinal chemistry,
Ahmed Kamal, and B Nagaseshadri, and V Lakshma Nayak, and Vunnam Srinivasulu, and Manda Sathish, and Jeevak Sopanrao Kapure, and C Suresh Reddy
April 2017, Chemical biology & drug design,
Ahmed Kamal, and B Nagaseshadri, and V Lakshma Nayak, and Vunnam Srinivasulu, and Manda Sathish, and Jeevak Sopanrao Kapure, and C Suresh Reddy
April 2016, Bioorganic & medicinal chemistry,
Ahmed Kamal, and B Nagaseshadri, and V Lakshma Nayak, and Vunnam Srinivasulu, and Manda Sathish, and Jeevak Sopanrao Kapure, and C Suresh Reddy
May 2019, Organic & biomolecular chemistry,
Ahmed Kamal, and B Nagaseshadri, and V Lakshma Nayak, and Vunnam Srinivasulu, and Manda Sathish, and Jeevak Sopanrao Kapure, and C Suresh Reddy
January 2018, European journal of medicinal chemistry,
Copied contents to your clipboard!